• A. J. Larner


This chapter examines the methods used in the cognitive function clinic, in particular the methodology used to assess the diagnostic accuracy of clinical signs and cognitive and non-cognitive screening instruments to assist in the diagnosis of dementia. The relevance of pragmatic diagnostic test accuracy studies, compared to experimental or proof of concept studies, as a better reflection of the idiom of clinical practice, is emphasized.


Dementia Diagnosis Diagnostic test accuracy studies Diagnostic criteria 


  1. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–9.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080.PubMedPubMedCentralCrossRefGoogle Scholar
  3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR), text revision. 4th ed. Washington: American Psychiatric Association; 2000.Google Scholar
  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  5. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496–503.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.CrossRefPubMedGoogle Scholar
  7. Bodemer N, Meder B, Gigerenzer G. Communicating relative risk changes with baseline risk: presentation format and numeracy matter. Med Decis Making. 2014;34:615–26.PubMedCrossRefGoogle Scholar
  8. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem. 2003;49:7–18.PubMedCrossRefGoogle Scholar
  9. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015. BMJ. 2015;351:h5527.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Brown JM. TYM (Test Your Memory) testing. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 209–29.CrossRefGoogle Scholar
  11. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–80.PubMedCrossRefGoogle Scholar
  12. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.CrossRefGoogle Scholar
  13. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.Google Scholar
  14. Cohen JF, Korevaar DA, Gatsonis CA, et al. STARD for abstracts. BMJ. 2017;358:j3571.Google Scholar
  15. Crutch SJ, Schott JM, Rabinovici GD, et al. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017;13:870–84.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Davis DH, Creavin ST, Noel-Storr A, et al. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studies. Cochrane Database Syst Rev. 2013;3:CD010460.Google Scholar
  17. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–9.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007a;6:734–46.PubMedCrossRefGoogle Scholar
  19. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson’s disease dementia: recommendations from the Movement Disorder Society task force. Mov Disord. 2007b;22:2314–24.PubMedCrossRefGoogle Scholar
  20. Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13:614–29. [Erratum Lancet Neurol. 2014;13:757]PubMedCrossRefGoogle Scholar
  21. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 2007;22:1689–707.PubMedCrossRefGoogle Scholar
  22. Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23–30.PubMedGoogle Scholar
  23. Gale TM, Larner AJ. Six-Item Cognitive Impairment Test (6CIT). In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 241–53.CrossRefGoogle Scholar
  24. Ghadiri-Sani M, Larner AJ. How to write a case report. Br J Hosp Med. 2014;75:207–10.CrossRefGoogle Scholar
  25. Gifford DR, Cummings JL. Evaluating dementia screening tests. Methodologic standards to rate their performance. Neurology. 1999;52:224–7.PubMedCrossRefGoogle Scholar
  26. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56:1129–35.PubMedCrossRefGoogle Scholar
  27. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006–14.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Green P, Lees-Haley PR, Allen LM. The word memory test and the validity of neuropsychological test scores. J Forens Neuropsychol. 2002;2:97–124.CrossRefGoogle Scholar
  30. Hancock P, Larner AJ. Cambridge Behavioural Inventory for the diagnosis of dementia. Prog Neurol Psychiatry. 2008;12(7):23–5.CrossRefGoogle Scholar
  31. Hancock P, Wike J, Larner AJ. Clinical experience with CANTAB-PAL in the diagnosis of Alzheimer’s disease. Poster presentation, 17th Alzheimer Europe Conference, Estoril, Portugal, 9–11 May 2007.Google Scholar
  32. Harris JM, Gall C, Thompson JC, et al. Classification and pathology of primary progressive aphasia. Neurology. 2013;81:1832–9.PubMedCrossRefGoogle Scholar
  33. Harris JM, Thompson JC, Gall C, et al. Do NIA-AA criteria distinguish Alzheimer’s disease from frontotemporal dementia? Alzheimers Dement. 2015;11:207–15.PubMedCrossRefGoogle Scholar
  34. Heath CA, Cooper SA, Murray K, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67:761–70.PubMedGoogle Scholar
  35. Hinkle DE, Wiersma W, Jurs SG. Applied statistics for the behavioral sciences. 5th ed. New York: Houghton Mifflin; 1998.Google Scholar
  36. Hodges JR. Cognitive assessment for clinicians. Oxford: Oxford University Press; 1994.Google Scholar
  37. Hodges JR. Cognitive assessment for clinicians. 2nd ed. Oxford: Oxford University Press; 2007.Google Scholar
  38. Hoglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord. 2017;32:853–64.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Hunter KM. Doctors’ stories. The narrative structure of medical knowledge. Princeton University Press: Princeton; 1991.Google Scholar
  40. Ismail Z, Mulsant BH, Herrmann N, Rapoport M, Nilsson M, Shulman K. Canadian Academy of Geriatric Psychiatry survey of brief cognitive screening instruments. Can Geriatr J. 2013;16:54–60.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Jefferis J, Taylor JP, Clarke M. Does cognitive impairment influence outcomes from cataract surgery? Results from a 1-year follow-up cohort study. Br J Ophthalmol. 2015;99:412–7.PubMedCrossRefGoogle Scholar
  42. Kapur N. The coin-in-the-hand test: a new “bedside” test for the detection of malingering in patients with suspected memory disorder. J Neurol Neurosurg Psychiatry. 1994;57:385–6.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Kim GH, Lee JH, Seo SW, et al. Seoul criteria for PiB(−) subcortical vascular dementia based on clinical and MRI variables. Neurology. 2014;82:1529–35.PubMedCrossRefGoogle Scholar
  44. Knottnerus JA, van Weel C. General introduction: evaluation of diagnostic procedures. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 1–17.Google Scholar
  45. Kraemer HC. Evaluating medical tests. Objective and quantitative guidelines. Newbury Park, CA: Sage Publications; 1992.Google Scholar
  46. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.PubMedCrossRefGoogle Scholar
  47. Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. 2. Longitudinal change. Int J Geriatr Psychiatry. 2006;21:698–9.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R) in day-to-day clinical practice. Age Ageing. 2007;36:685.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. Cambridge: Cambridge University Press; 2008.CrossRefGoogle Scholar
  50. Larner AJ. ACE-R: cross-sectional and longitudinal use for cognitive assessment. In: Fisher A, Hanin I, editors. New trends in Alzheimer and Parkinson related disorders: ADPD 2009. Collection of selected free papers from the 9th International Conference on Alzheimer’s and Parkinson’s disease AD/PD. Prague, Czech Republic, 11–15 March 2009. Bologna: Medimond International Proceedings; 2009a. p. 103–7.Google Scholar
  51. Larner AJ. Addenbrooke’s Cognitive Examination-Revised: cross-sectional and longitudinal use for cognitive assessment. Neurodegener Dis. 2009b;6(Suppl 1):194.Google Scholar
  52. Larner AJ. An approach to the cognitively-impaired adult. 2011a. Accessed 07 Nov 2017.
  53. Larner AJ. Teleneurology by internet and telephone. A study in self-help. London: Springer; 2011b.CrossRefGoogle Scholar
  54. Larner AJ. Camptodactyly: a 10-year series. Eur J Dermatol. 2011c;21:771–5.PubMedGoogle Scholar
  55. Larner AJ. Pragmatic diagnostic accuracy studies., 28 Aug 2012.
  56. Larner AJ. Neuropsychological neurology: the neurocognitive impairments of neurological disorders. 2nd ed. Cambridge: Cambridge University Press; 2013a.CrossRefGoogle Scholar
  57. Larner AJ. Introduction to cognitive screening instruments: rationale, desiderata, and assessment of utility. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013b. p. 1–14.CrossRefGoogle Scholar
  58. Larner AJ. Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach. Dement Geriatr Cogn Disord Extra. 2013c;3:60–5.CrossRefGoogle Scholar
  59. Larner AJ. Effect size (Cohen’s d) of cognitive screening instruments examined in pragmatic diagnostic accuracy studies. Dement Geriatr Cogn Dis Extra. 2014;4:236–41.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Larner AJ. Speed versus accuracy in cognitive assessment when using CSIs. Prog Neurol Psychiatry. 2015a;19(1):21–4.CrossRefGoogle Scholar
  61. Larner AJ. Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics (Basel). 2015b;5:504–12.CrossRefGoogle Scholar
  62. Larner AJ. Diagnostic test accuracy studies in dementia. A pragmatic approach. London: Springer; 2015c.Google Scholar
  63. Larner AJ. Optimizing the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or Youden index? Dement Geriatr Cogn Disord. 2015d;39:167–75.PubMedCrossRefPubMedCentralGoogle Scholar
  64. Larner AJ. Correlation or limits of agreement? Applying the Bland-Altman approach to the comparison of cognitive screening instruments. Dement Geriatr Cogn Disord. 2016;42:247–54.PubMedCrossRefPubMedCentralGoogle Scholar
  65. Larner AJ. Short Montreal Cognitive Assessment: validation and reproducibility. J Geriatr Psychiatry Neurol. 2017a;30:104–8.PubMedCrossRefPubMedCentralGoogle Scholar
  66. Larner AJ. Transient global amnesia. From patient encounter to clinical neuroscience. London: Springer; 2017b.CrossRefGoogle Scholar
  67. Larner AJ. Neurology and literature. Neurosciences and History. 2017c;5(1):47–51.Google Scholar
  68. Larner AJ. Assessment of cognitive function. In: Severn A, editor. Cognitive changes after surgery. London: Springer; 2018 (in press).Google Scholar
  69. Larner AJ, Coles AJ, Scolding NJ, Barker RA. The A-Z of neurological practice. A guide to clinical neurology. 2nd ed. London: Springer; 2011.Google Scholar
  70. Lees RA, Hendry BK, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32:1072–8.PubMedCrossRefGoogle Scholar
  71. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1–9.PubMedCrossRefGoogle Scholar
  72. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27:349–56.PubMedPubMedCentralCrossRefGoogle Scholar
  73. Mallett S, Halligan S, Thompson M, Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ. 2012;344:e3999.CrossRefGoogle Scholar
  74. Mathew R, Bak TH, Hodges JR. Diagnostic criteria for corticobasal syndrome: a comparative study. J Neurol Neurosurg Psychiatry. 2012;83:405–10.PubMedCrossRefGoogle Scholar
  75. Mattis S. Mental status examination for organic mental syndrome in the elderly. In: Bellack R, Karasu B, editors. Geriatric psychiatry. New York: Grune and Stratton; 1976. p. 77–121.Google Scholar
  76. Mattis S. Dementia Rating Scale. Windsor: NFER-Nelson; 1992.Google Scholar
  77. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113–24.PubMedCrossRefGoogle Scholar
  78. McKeith IG, Perry EK, Perry RH, for the Consortium on Dementia with Lewy Bodies. Report of the second dementia with Lewy body international workshop. Neurology. 1999;53:902–5.PubMedCrossRefGoogle Scholar
  79. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72.PubMedCrossRefGoogle Scholar
  80. McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88–100.PubMedPubMedCentralCrossRefGoogle Scholar
  81. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer’s disease. Neurology. 1984;34:939–44.PubMedCrossRefGoogle Scholar
  82. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Report of the Work Group on Frontotemporal Dementia and Pick’s disease. Arch Neurol. 2001;58:1803–9.PubMedCrossRefGoogle Scholar
  83. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9.PubMedPubMedCentralCrossRefGoogle Scholar
  84. Metz CE. Basic principles of ROC analysis. Semin Nucl Med. 1978;8:283–98.PubMedCrossRefGoogle Scholar
  85. Mitchell AJ. Sensitivity x PPV is a recognized test called the clinical utility index (CUI+). Eur J Epidemiol. 2011;26:251–2.PubMedCrossRefGoogle Scholar
  86. Mitchell AJ, Malladi S. Screening and case-finding tools for the detection of dementia. Part I: evidence-based meta-analysis of multidomain tests. Am J Geriatr Psychiatry. 2010a;18:759–82.PubMedCrossRefPubMedCentralGoogle Scholar
  87. Mitchell AJ, Malladi S. Screening and case-finding tools for the detection of dementia. Part II: evidence-based meta-analysis of single-domain tests. Am J Geriatr Psychiatry. 2010b;18:783–800.PubMedCrossRefPubMedCentralGoogle Scholar
  88. Mitchell AJ, Beaumont H, Ferguson D, Yadegarfar M, Stubbs B. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130:439–51.PubMedCrossRefGoogle Scholar
  89. Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer’s Disease Assessment Scale that broaden its scope. The Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl2):S13–21.PubMedCrossRefGoogle Scholar
  90. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.PubMedCrossRefGoogle Scholar
  91. Noel-Storr AH, McCleery JM, Richard E, et al. Reporting standards for studies of diagnostic test accuracy in dementia: the STARDdem Initiative. Neurology. 2014;83:364–73.PubMedPubMedCentralCrossRefGoogle Scholar
  92. Norman G, Monteiro S, Salama S. Sample size calculations: should the emperor’s clothes be off the peg or made to measure? BMJ. 2012;345:e5728.Google Scholar
  93. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8.PubMedPubMedCentralCrossRefGoogle Scholar
  94. Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379–88.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer’s Disease. J Neurol Neurosurg Psychiatry. 2006;77:714–8.PubMedPubMedCentralCrossRefGoogle Scholar
  96. Quinn TJ, Takwoingi Y. Assessment of the utility of cognitive screening instruments. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 15–34.CrossRefGoogle Scholar
  97. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.PubMedPubMedCentralCrossRefGoogle Scholar
  98. Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington’s disease based on natural history. Mov Disord. 2014;29:1335–41.PubMedCrossRefGoogle Scholar
  99. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993;43:250–60.PubMedCrossRefGoogle Scholar
  100. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer’s disease. Am J Psychiatry. 1984;141:1356–64.PubMedCrossRefGoogle Scholar
  101. Sachdev P, Kalaria R, O’Brien J, et al. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord. 2014;28:206–18.PubMedPubMedCentralCrossRefGoogle Scholar
  102. Sackett DL, Haynes RB. The architecture of diagnostic research. In: Knottnerus JA, editor. The evidence base of clinical diagnosis. London: BMJ Books; 2002. p. 19–38.Google Scholar
  103. Seeher KM, Brodaty H. The General Practitioner Assessment of Cognition (GPCOG). In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 231–9.CrossRefGoogle Scholar
  104. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.PubMedPubMedCentralCrossRefGoogle Scholar
  105. Stern RA, White T. Neuropsychological assessment battery. Lutz, FL: Psychological Assessment Resources, Inc.; 2003.Google Scholar
  106. Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131–46.PubMedCrossRefGoogle Scholar
  107. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–93.PubMedCrossRefGoogle Scholar
  108. Tate RL. A compendium of tests, scales, and questionnaires. The practitioner’s guide to measuring outcomes after acquired brain impairment. Hove: Psychology Press; 2010.Google Scholar
  109. Tombaugh TN. The test of memory malingering. Toronto: Multi-Health Systems; 1996.Google Scholar
  110. Tombaugh TN. The test of memory malingering (TOMM): normative data from cognitively intact and cognitively impaired individuals. Psychol Assess. 1997;9:260–6.CrossRefGoogle Scholar
  111. van Straaten EC, Scheltens P, Knol DL, et al. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke. 2003;34:1907–12.PubMedCrossRefGoogle Scholar
  112. Varma AR, Snowden JS, Lloyd JJ, et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999;66:184–8.PubMedPubMedCentralCrossRefGoogle Scholar
  113. Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002;21:1237–56.PubMedCrossRefGoogle Scholar
  114. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med. 2004;140:189–202.PubMedCrossRefGoogle Scholar
  115. Williamson J, Larner AJ. Transient global amnesia. Br J Hosp Med. 2015;76:C186–8.CrossRefGoogle Scholar
  116. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Int Med. 2004;256:240–6.CrossRefGoogle Scholar
  117. World Health Organization. ICD-10. International statistical classification of diseases and related health problems: tenth revision. 2nd ed. Geneva: World Health Organization; 2004.Google Scholar
  118. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–5.PubMedCrossRefGoogle Scholar
  119. Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659–68. [Erratum Brain. 2012;135:1335]PubMedPubMedCentralCrossRefGoogle Scholar
  120. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental tool in clinical medicine. Clin Chem. 1993;39:561–77.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • A. J. Larner
    • 1
  1. 1.Cognitive Function ClinicWalton Centre for Neurology and NeurosurgeryLiverpoolUK

Personalised recommendations